# temozolomide

NDC: 75834-145
Generic name: temozolomide
Labeler / Manufacturer: Nivagen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20211207

FDA application: ANDA213328

## Active ingredients

- TEMOZOLOMIDE: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75834-145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75834-145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27e5a781-e4f2-4489-9def-7971d0b86d9c